Last SFr.112.30 CHF
Change Today +1.20 / 1.08%
Volume 365.2K
ATLN On Other Exchanges
Symbol
Exchange
OTC US
Xetra
SIX Swiss Ex
OTC US
As of 11:43 AM 09/30/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for actelion ltd-reg (ATLN)

Year over year, Actelion Ltd. has been able to grow revenues from SFr.1.7B CHF to SFr.1.8B CHF. Most impressively, the company has been able to reduce the percentage of sales devoted to income tax expense from 3.20% to -1.28%. This was a driver that led to a bottom line growth from SFr.303.2M CHF to SFr.452.5M CHF.
View Income Statement In U.S. Dollar
Currency in
Millions of Swiss Francs
As of:Dec 31
2010
CHF
Dec 31
2011
CHF
Dec 31
2012
Reclassified
CHF
Dec 31
2013
CHF
4 Year
Trend
Revenues1,929.01,796.11,728.41,785.7
TOTAL REVENUES1,929.01,796.11,728.41,785.7
Cost of Goods Sold684.5654.2651.4614.0
GROSS PROFIT1,244.41,141.91,077.01,171.7
Selling General & Admin Expenses, Total744.1749.9607.7628.3
Depreciation & Amortization, Total32.539.233.844.7
OTHER OPERATING EXPENSES, TOTAL776.6789.1641.4673.1
OPERATING INCOME467.9352.8435.6498.7
Interest Expense-21.3-20.3-12.6-12.2
Interest and Investment Income3.26.22.12.7
NET INTEREST EXPENSE-18.1-14.1-10.5-9.5
Income (Loss) on Equity Investments-------0.5
Currency Exchange Gains (Loss)26.0-8.0-20.5-21.9
Other Non-Operating Income (Expenses)-24.315.69.618.4
EBT, EXCLUDING UNUSUAL ITEMS451.5346.3414.1485.2
Merger & Restructuring Charges-----8.6-2.9
Gain (Loss) on Sale of Investments---55.3----
Other Unusual Items, Total-10.6-360.4-47.1-52.5
Legal Settlements---360.4-41.6-39.2
Other Unusual Items-------12.9
EBT, INCLUDING UNUSUAL ITEMS440.9-69.3358.5429.7
Income Tax Expense50.377.055.2-22.8
Earnings from Continuing Operations390.6-146.3303.2452.5
NET INCOME390.6-146.3303.2452.5
NET INCOME TO COMMON INCLUDING EXTRA ITEMS390.6-146.3303.2452.5
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS390.6-146.3303.2452.5
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATLN:VX SFr.112.30 CHF +1.20

ATLN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioMarin Pharmaceutical Inc $72.16 USD -0.84
Ipsen SA €38.94 EUR +0.095
Meda AB kr101.40 SEK +1.60
Orion OYJ €31.00 EUR +0.05
United Therapeutics Corp $128.65 USD -4.06
View Industry Companies
 

Industry Analysis

ATLN

Industry Average

Valuation ATLN Industry Range
Price/Earnings 17.8x
Price/Sales 6.1x
Price/Book 6.3x
Price/Cash Flow 16.2x
TEV/Sales 5.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTELION LTD-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.